Dopamine plasma membrane transport protein: Difference between revisions
Jump to navigation
Jump to search
imported>Robert Badgett No edit summary |
imported>Meg Taylor (subpages) |
||
| Line 1: | Line 1: | ||
{{subpages}} | |||
'''Dopamine plasma membrane transport proteins''' are [[catecholamine plasma membrane transport protein]]s that are "sodium chloride-dependent neurotransmitter symporters located primarily on the plasma membrane of dopaminergic neurons. They remove [[dopamine]] from the extracellular space by high affinity reuptake into presynaptic terminals and are the target of [[dopamine uptake inhibitor]]s."<ref>{{MeSH}}</ref> | '''Dopamine plasma membrane transport proteins''' are [[catecholamine plasma membrane transport protein]]s that are "sodium chloride-dependent neurotransmitter symporters located primarily on the plasma membrane of dopaminergic neurons. They remove [[dopamine]] from the extracellular space by high affinity reuptake into presynaptic terminals and are the target of [[dopamine uptake inhibitor]]s."<ref>{{MeSH}}</ref> | ||
Revision as of 07:45, 30 September 2009
- The content on this page originated on Wikipedia and is yet to be significantly improved. Contributors are invited to replace and add material to make this an original article.
Dopamine plasma membrane transport proteins are catecholamine plasma membrane transport proteins that are "sodium chloride-dependent neurotransmitter symporters located primarily on the plasma membrane of dopaminergic neurons. They remove dopamine from the extracellular space by high affinity reuptake into presynaptic terminals and are the target of dopamine uptake inhibitors."[1]
Clinical pharmacology
Dopamine plasma membrane transport proteins are the targets of dopamine uptake inhibitors.
References
- ↑ Anonymous (2024), Dopamine plasma membrane transport protein (English). Medical Subject Headings. U.S. National Library of Medicine.